Matches in SemOpenAlex for { <https://semopenalex.org/work/W2230649060> ?p ?o ?g. }
- W2230649060 abstract "Migraine and cluster headaches are severe and disabling. Migraine affects up to 18% of women, while cluster headaches are much less common (0.2% of the population). A number of acute and prophylactic therapies are available. Hyperbaric oxygen therapy (HBOT) is the therapeutic administration of 100% oxygen at environmental pressures greater than one atmosphere, while normobaric oxygen therapy (NBOT) is oxygen administered at one atmosphere. This is an updated version of the original Cochrane review published in Issue 3, 2008 under the title 'Normobaric and hyperbaric oxygen for migraine and cluster headache'.To examine the efficacy and safety of normobaric oxygen therapy (NBOT) and hyperbaric oxygen therapy (HBOT) in the treatment and prevention of migraine and cluster headache.We updated searches of the following databases up to 15 June 2015: CENTRAL (the Cochrane Library), MEDLINE, EMBASE, and CINAHL. For the original review we searched the following databases up to May 2008: CENTRAL, MEDLINE, EMBASE, CINAHL, DORCTIHM, and reference lists from relevant articles. We handsearched relevant journals and contacted researchers to identify trials.Randomised controlled trials comparing HBOT or NBOT with one another, other active therapies, placebo (sham) interventions, or no treatment in participants with migraine or cluster headache.Three review authors independently extracted data and assessed the quality of the evidence using the GRADE approach.In this update, we included 11 trials with 209 participants. Five trials (103 participants) compared HBOT versus sham therapy for acute migraine, three trials compared NBOT to sham therapy or ergotamine tartrate for cluster headache (145 participants), two trials evaluated HBOT for cluster headache (29 participants), and one trial (56 participants) compared NBOT to sham for a mixed group of headache. The risk of bias varied considerably across these trials but in general trial quality was poor to moderate. One trial may not have been truly randomised and two included studies were reported as abstracts only. Seven trials did not indicate allocation concealment or randomisation method. Notably, 10 of the 11 trials used a sham comparator therapy and masked the outcome assessor to allocation.We pooled data from three trials, which suggested that HBOT was effective in relieving migraine headaches compared to sham therapy (risk ratio (RR) 6.21, 95% CI 2.41 to 16.00; 58 participants, three trials). The quality of evidence was low, having been downgraded for small crossover studies with incomplete reporting. There was no evidence that HBOT could prevent migraine episodes, reduce the incidence of nausea and vomiting, or reduce the requirement for rescue medication. There was no evidence that HBOT was effective for the termination of cluster headache (RR 11.38, 95% CI 0.77 to 167.85; P = 0.08) (one trial), but this trial had low power.NBOT was effective in terminating cluster headache compared to sham in a single small study (RR 7.88, 95% CI 1.13 to 54.66), but not superior to ergotamine administration in another small trial (RR 1.17, 95% CI 0.94 to 1.46; P = 0.16). A third trial reported a statistically significant difference in the proportion of attacks successfully treated with oxygen (117 of 150 attacks were successfully treated with NBOT (78%) versus 30 of 148 attacks treated with NBOT (20%)). The proportion of responders was consistent across these three trials, and suggested more than 75% of headaches were likely to respond to NBOT.No serious adverse events during HBOT or NBOT were reported.Since the last version of this review, two new included studies have provided additional information to change the conclusions. There was some evidence that HBOT was effective for the termination of acute migraine in an unselected population, and some evidence that NBOT was similarly effective in cluster headache. Given the cost and poor availability of HBOT, more research should be done on patients unresponsive to standard therapy. NBOT is cheap, safe, and easy to apply, so will probably continue to be used despite the limited evidence in this review." @default.
- W2230649060 created "2016-06-24" @default.
- W2230649060 creator A5009846711 @default.
- W2230649060 creator A5037072988 @default.
- W2230649060 creator A5058307774 @default.
- W2230649060 creator A5060782749 @default.
- W2230649060 creator A5066882319 @default.
- W2230649060 creator A5091236832 @default.
- W2230649060 date "2015-12-28" @default.
- W2230649060 modified "2023-09-27" @default.
- W2230649060 title "Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache" @default.
- W2230649060 cites W1480102476 @default.
- W2230649060 cites W1507326941 @default.
- W2230649060 cites W1510585453 @default.
- W2230649060 cites W151349690 @default.
- W2230649060 cites W1533056877 @default.
- W2230649060 cites W1591155495 @default.
- W2230649060 cites W1619588441 @default.
- W2230649060 cites W1911657479 @default.
- W2230649060 cites W1964130465 @default.
- W2230649060 cites W1971659903 @default.
- W2230649060 cites W1972778833 @default.
- W2230649060 cites W1981935114 @default.
- W2230649060 cites W1991191376 @default.
- W2230649060 cites W1996081907 @default.
- W2230649060 cites W1999595139 @default.
- W2230649060 cites W1999890587 @default.
- W2230649060 cites W2001394872 @default.
- W2230649060 cites W2001845443 @default.
- W2230649060 cites W2005313675 @default.
- W2230649060 cites W2009422545 @default.
- W2230649060 cites W2010562609 @default.
- W2230649060 cites W2013989909 @default.
- W2230649060 cites W2014707764 @default.
- W2230649060 cites W2022741617 @default.
- W2230649060 cites W2031157475 @default.
- W2230649060 cites W2034871501 @default.
- W2230649060 cites W2043271744 @default.
- W2230649060 cites W2057514499 @default.
- W2230649060 cites W2058086025 @default.
- W2230649060 cites W2064006234 @default.
- W2230649060 cites W2067610113 @default.
- W2230649060 cites W2083697963 @default.
- W2230649060 cites W2088362594 @default.
- W2230649060 cites W2094713596 @default.
- W2230649060 cites W2107328434 @default.
- W2230649060 cites W2108344016 @default.
- W2230649060 cites W2108490520 @default.
- W2230649060 cites W2110078996 @default.
- W2230649060 cites W2119011129 @default.
- W2230649060 cites W2126220651 @default.
- W2230649060 cites W2135664461 @default.
- W2230649060 cites W2140957052 @default.
- W2230649060 cites W2141410286 @default.
- W2230649060 cites W2143969729 @default.
- W2230649060 cites W2144128160 @default.
- W2230649060 cites W2155653053 @default.
- W2230649060 cites W2155727751 @default.
- W2230649060 cites W2158835218 @default.
- W2230649060 cites W2163487803 @default.
- W2230649060 cites W2167997202 @default.
- W2230649060 cites W2168033298 @default.
- W2230649060 cites W2171451795 @default.
- W2230649060 cites W2230649060 @default.
- W2230649060 cites W2413232900 @default.
- W2230649060 cites W2416084447 @default.
- W2230649060 cites W2470421266 @default.
- W2230649060 cites W2489894369 @default.
- W2230649060 cites W3025475595 @default.
- W2230649060 cites W4232086954 @default.
- W2230649060 cites W4232777839 @default.
- W2230649060 cites W4233871637 @default.
- W2230649060 cites W4234655367 @default.
- W2230649060 cites W4252093563 @default.
- W2230649060 cites W4255257652 @default.
- W2230649060 cites W4298184796 @default.
- W2230649060 cites W164086321 @default.
- W2230649060 doi "https://doi.org/10.1002/14651858.cd005219.pub3" @default.
- W2230649060 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26709672" @default.
- W2230649060 hasPublicationYear "2015" @default.
- W2230649060 type Work @default.
- W2230649060 sameAs 2230649060 @default.
- W2230649060 citedByCount "28" @default.
- W2230649060 countsByYear W22306490602015 @default.
- W2230649060 countsByYear W22306490602017 @default.
- W2230649060 countsByYear W22306490602018 @default.
- W2230649060 countsByYear W22306490602019 @default.
- W2230649060 countsByYear W22306490602020 @default.
- W2230649060 countsByYear W22306490602021 @default.
- W2230649060 countsByYear W22306490602022 @default.
- W2230649060 countsByYear W22306490602023 @default.
- W2230649060 crossrefType "journal-article" @default.
- W2230649060 hasAuthorship W2230649060A5009846711 @default.
- W2230649060 hasAuthorship W2230649060A5037072988 @default.
- W2230649060 hasAuthorship W2230649060A5058307774 @default.
- W2230649060 hasAuthorship W2230649060A5060782749 @default.
- W2230649060 hasAuthorship W2230649060A5066882319 @default.
- W2230649060 hasAuthorship W2230649060A5091236832 @default.
- W2230649060 hasBestOaLocation W22306490602 @default.
- W2230649060 hasConcept C118552586 @default.